June 2, 2015

The latest addition to Teva’s roster of medication is its generic version of Intuniv (guanfacine) extended release tablets, a non-stimulant meant to treat attention deficit hyperactivity disorder.

July 5, 2012

Actavis has received a preliminary approval for a generic drug for treating high blood pressure, the drug maker said Thursday.

February 28, 2011

The Food and Drug Administration has approved a new use for a Shire drug to treat attention deficit hyperactivity disorder, Shire said Monday.

December 13, 2010

Drug maker Shire has filed a patent infringement suit against Watson Pharmaceuticals and Impax Labs in response to their attempt to win approval from the Food and Drug Administration for a generic version of a Shire drug.

May 20, 2010

British drug maker Shire presented late-stage clinical study data at a psychiatric meeting Friday indicating...

May 19, 2010

British drug maker Shire will present data on two attention deficit hyperactivity disorder treatments in...

March 15, 2010

Teva is hoping to get a generic drug for treating attention deficit hyperactivity disorder into...